Zurueck zur Suche

Reporte zur Charge U002535

Verknuepft ueber VAERS_ID mit VAERSDATA, Vax und Symptoms

11Reporte angezeigt
0Todesfaelle
0Hospitalisiert
0Lebensbedrohlich
0Bleibende Schaeden
IN 2 MN 2 SC 2 NY 1 IA 1 NJ 1 VA 1 MI 1

VAERS 2455494

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) · Charge U002535

gering
Staat
NY
Alter
4,0
Geschlecht
F
Eingang
23.09.2022
Impfdatum
20.07.2022
Beginn
20.07.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product storage error

Symptomtext

No additional AE reported.; PROQUAD was administered after a temperature excursion to a patient.; This spontaneous report was received from a nurse referring to a patient of unknown age or gender. The patients' pertinent medical history, concomitant medications, concurrent conditions, and previous drug reactions or allergies were not reported. There were two temperature excursions, with the same time/temp on different days. The temperature excursions for measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) (recombinant human albumin [rHA]) occurred at -14.2 degrees Celsius for 1 hour 11 minutes on 13-JUN-2022 and 24-JUN-2022, respectively. On 20-JUL-2022, the patient was vaccinated with improperly stored measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) (recombinant human albumin [rHA]) subcutaneous injection, once, lot #U002535, expiration date: 24-JUL-2022, administered for prophylaxis (strength, dose, and route of administration were not provided) (Product storage error). There was no previous temperature excursion. No additional adverse event (AE) reported. Follow-up information was received from a nurse on 16-SEP-2022 referring to a 4-year-old female patient. The suspect vaccine was administered subcutaneously at right arm. Patient information and additional information about vaccination related were updated.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2416619

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) · Charge U002535

gering
Staat
IA
Alter
4,0
Geschlecht
U
Eingang
20.08.2022
Impfdatum
27.07.2022
Beginn
27.07.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered Incorrect route of product administration No adverse event

Symptomtext

no reported side effects.; an expired dose of PROQUAD was administered to a patient; Subcutaneous injection formulation administered by other route; This spontaneous report was received from an office administrator referring to a 4-year-old unknown gender patient. Pertinent medical history, concomitant medications and drug reactions/allergies were not reported. On 27-JUL-2022, the patient was vaccinated with an expired dose of measles, mumps, rubella and varicella (oka-merck) virus vaccine live (albumin status recombinant Human albumin (rHA)) (PROQUAD) 0.5 mL x1 dose, lot #U002535, expiration date: 24-JUL-2022, intramuscularly (IM) for prophylaxis (strength was not provided) (incorrect route of product administration, expired product administered) which was reconstituted with sterile diluent (MERCK STERILE DILUENT) IM (lot # T029528, expiration date: 14-APR-2023) (dose, frequency, strength, formulation was not provided) which was not expired. Reporter confirmed that the expired measles, mumps, rubella and varicella (oka-merck) virus vaccine live (rHA) (PROQUAD) had no temperature excursions. There was no adverse event reported and reported side effects (no adverse event).

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
MERCK STERILE DILUENT
Allergien
-
Vorherige Impfungen
-

VAERS 2203389

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) · Charge U002535

gering
Staat
MN
Alter
4,0
Geschlecht
U
Eingang
29.03.2022
Impfdatum
17.03.2022
Beginn
17.03.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Accidental overdose No adverse event

Symptomtext

No additional AE reported; patient was accidently administered a dose of V ARlV AX and PROQUAD on 17-MAR-2022; This spontaneous report was received from a registered nurse and refers to a 4-year-old patient of unknown gender. The patient's medical history, concurrent conditions, concomitant medications and drug allergies were not reported. On 17-MAR-2022, the patient was vaccinated with varicella virus vaccine live (oka/merck) (VARIVAX), once, (lot number T022315, expiration date 30-JUN-2022) and measles, mumps, rubella and varicella (oka-merck) virus vaccine live, rHA (recombinant human albumin) (PROQUAD), once, (lot number U002535, expiration date 24-JUL-2022) for prophylaxis (accidental overdose). For both vaccines dose, formulation, route of administration and injection site were not provided. No additional adverse events were reported.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Accidental overdose
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2187508

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) · Charge U002535

gering
Staat
MN
Alter
4,0
Geschlecht
F
Eingang
18.03.2022
Impfdatum
17.03.2022
Beginn
-
Tage bis Beginn
-
Dosis
1
Route/Site
IM / LL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Extra dose administered Wrong product administered

Symptomtext

Patient was given a Proquad vaccine which contains Varicella and an additional Varicella vaccine at the same time.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Extra dose administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
None
Vorgeschichte
None
Andere Medikamente
None
Allergien
NKA
Vorherige Impfungen
-

VAERS 2017316

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) · Charge U002535

gering
Staat
NJ
Alter
-
Geschlecht
U
Eingang
08.01.2022
Impfdatum
-
Beginn
-
Tage bis Beginn
-
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Product storage error

Symptomtext

This spontaneous report was received from a medical assistance referring to a patient of unknown age and gender. The patient's concurrent conditions, pertinent medical history, concomitant medications, drug reactions or allergies were no reported. On an unspecified date, the patient was vaccinated with improperly stored measles, mumps, rubella and varicella (oka-merck) virus vaccine live(PROQUAD) rHA (Lot# U002535and expiration date 24-JUL-2022) (exact dose and frequency were not reported) as prophylaxis. (product storage error). The vaccine underwent a temperature excursion of 6.4 Fahrenheit for 2 hours 30 minutes and 0 seconds. There was no previous temperature excursion. No further information provided.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product storage error
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1954448

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) · Charge U002535

gering
Staat
VA
Alter
4,0
Geschlecht
U
Eingang
16.12.2021
Impfdatum
30.11.2021
Beginn
30.11.2021
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Incorrect route of product administration No adverse event

Symptomtext

Patient had no experienced any side effects; Vaccine given intramuscularly instead of subcutaneously; This spontaneous report was received from registered nurse referring to a 4 year old male patient of unknown gender. The information about patient's concurrent conditions, medical history, concomitant medications was not reported. On 30-NOV-2021, the patient was vaccinated with measles, mumps, rubella and varicella (oka-merck) virus vaccine live (recombinant Human albumin (rHA) or human serum albumin (HAS) (PROQUAD) 0.5 mL, intramuscularly for prophylaxis (incorrect route of product administration) (strength, vaccination scheme, anatomical location were not reported; lot number U002535 has been verified to be a valid lot number, expiration date was 24-JUL-2022). At the time, the patient had not experienced any adverse event (no adverse event). No product quality complaints (PQC) were reported.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Incorrect route of product administration
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1440748

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) · Charge U002535

gering
Staat
MI
Alter
1,0
Geschlecht
F
Eingang
01.07.2021
Impfdatum
15.06.2021
Beginn
15.06.2021
Tage bis Beginn
0,0
Dosis
1
Route/Site
- / LL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Wrong product administered

Symptomtext

I administered both MMR and MMRV to the patient that was due for MMR and varicella.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Wrong product administered
Hospital-Tage
-
Labordaten
none
Aktuelle Erkrankungen
none
Vorgeschichte
none
Andere Medikamente
none
Allergien
none
Vorherige Impfungen
-

VAERS 1405158

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) · Charge U002535

gering
Staat
IN
Alter
-
Geschlecht
U
Eingang
17.06.2021
Impfdatum
27.05.2021
Beginn
27.05.2021
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Product storage error

Symptomtext

improperly stored and administered Proquad; This spontaneous report was received from a medical assistant and refers to a patient of unknown gender and age. The patient's concurrent conditions, medical history and cocomitant therapies were not provided. On 27-MAY-2021, the patient was vaccinated with an improperly stored dose of measles, mumps, rubella and varicella (oka-merck) virus vaccine live recombinant human albumin (rHA) (PROQUAD) lot # U002535, expiration date 24-JUL-2020 (dose and route of administration were not provided) for prophylaxis. The vaccine was improperly stored in temperature excursion of -14 degress Celsius for 35 hours and 43 minutes. There was no previous temperature excursion. Data logger was involved. The report is linked to 2106USA001746, received from the same reporter.; Sender's Comments: US-009507513-2106USA001746:

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product storage error
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1401617

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) · Charge U002535

gering
Staat
IN
Alter
-
Geschlecht
U
Eingang
16.06.2021
Impfdatum
01.06.2021
Beginn
01.06.2021
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Product storage error

Symptomtext

proquad improperly stored and administered/ -14 C for 35 h 43 minutes; This spontaneous report was received from a medical assistant and refers to a patient of unknown gender and age. The patient's concurrent conditions, medical history and concomitant therapies were not provided. On 01-JUN-2021, the patient was vaccinated with an improperly stored dose of measles, mumps, rubella and varicella (oka-merck) virus vaccine live recoant Human albumin (rHA)(PROQUAD) lot # U002535, expiration date 24-JUL-2022 (dose and route of administration were not provided) for prophylaxis. The dose was improperly stored in temperature excursion of -14 degress Celsius for 35 hours and 43 minutes. There was no previous temperature excursion. Data logger was involved. The report is linked to MARRS # 2106USA001746, received from the same reporter.; Sender's Comments: US-009507513-2106USA001746:

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product storage error
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1398375

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) · Charge U002535

gering
Staat
SC
Alter
1,0
Geschlecht
U
Eingang
15.06.2021
Impfdatum
10.05.2021
Beginn
10.05.2021
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product storage error

Symptomtext

No additional AE; temperature excursion on PROQUAD; This spontaneous report has been received from a medical assistant referring to a 12 months old patient of unknown gender. Information regarding the patient's medical history, drug reactions or allergies, concurrent conditions and concomitant medications was not reported. On 10-MAY-2021, the patient was vaccinated with temperature excursion dose of measles, mumps, rubella and varicella (oka-merck) virus vaccine live (recombinant human albumin (rHA)) (PROQUAD) (strength, dose, route of administration and anatomical location were not provided, lot number U002535 has been verified to be a valid lot number, expiration date reported as 24-JUL-2022) for prophylaxis (product storage error). The vaccine underwent temperature excursion at -10.8 degree Celsius (C) for 1 hours 45 minutes. It was reported that there were no previous temperature excursions. The digital data logger was involved in recording excursion details. No additional adverse events (AEs) were reported. This is one of several reports received from the same reporter. ; Sender's Comments: US-009507513-2105USA003786: US-009507513-2105USA004015: US-009507513-2106USA001126:

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1353730

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) · Charge U002535

gering
Staat
SC
Alter
4,0
Geschlecht
U
Eingang
27.05.2021
Impfdatum
12.05.2021
Beginn
12.05.2021
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product storage error

Symptomtext

No additional AE; temperature excursion; This spontaneous report was received from a medical assistant referring to a 4 years old patient of unknown gender. The patient's concomitant medication, pertinent medical history and drug reactions/allergies were not reported. On 12-MAY-2021, the patient was vaccinated with measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) (therapy type: rHA) (strength, dose and route were not provided; lot# was U002535 and expiration date was 24-JUL-2021) for prophylaxis, which was involved a temperature excursion (product storage error). No additional adverse event was reported. The administered dose experienced an temperature excursion from -50 degree Celsius (C) to -15 degree C (16.8 degree C) for 1 hour 45 minutes 0 seconds. There was no previous temperature excursion. It was detected by a data logger.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-